M&As this week: Confluent Medical, Nissha Medical International, Assurex Health

11 August 2016 (Last Updated August 11th, 2016 18:30)

In a move to expand its portfolio of medical technologies, contract manufacturer of Nitinol-based and balloon catheter medical devices, Confluent Medical Technologies has acquired ETE Medical and its operating subsidiaries Biomedical Structures (BMS) and Modified Polymer Components (MPC).

In a move to expand its portfolio of medical technologies, contract manufacturer of Nitinol-based and balloon catheter medical devices, Confluent Medical Technologies has acquired ETE Medical and its operating subsidiaries Biomedical Structures (BMS) and Modified Polymer Components (MPC).

Following the transaction, the combined company will offer complementary, best-of-class technologies to provide high-quality, cost-effective medical device contract manufacturing, testing and design services to its customers.

Nissha Medical International, a wholly-owned subsidiary of Nissha Printing, a manufacturer of industrial materials and electronic components, intends to acquire Graphic Controls Holdings from WestView Capital Partners, a private equity firm, and others, for approximately $135m.

"The acquisition will provide the acquirer with an opportunity to venture into medical devices and contract manufacturing businesses."

Following the transaction, which will be closed in August 2016, Graphic Controls, its subsidiary Graphic Controls Acquisition, and its related group companies will become subsidiaries of Nissha Printing.

The acquisition will provide the acquirer with an opportunity to venture into medical devices and contract manufacturing businesses.

Assurex Health has been acquired by Myriad Merger Sub, a wholly-owned subsidiary of molecular diagnostic company, Myriad Genetics. The acquisition will enable Myriad to expand its portfolio and strengthen its position in psychotropic drugs business.

The $410m deal is planned to be funded through cash on hand and possibly short-term debt.

Pursuant to the agreement, which is expected to close before the end of Q1 2017, Myriad Merger Sub will be merged with and into Assurex, while the latter will become a wholly-owned subsidiary of Myriad.